These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 30537634)
1. Pseudoginsenoside-F11 attenuates cognitive impairment by ameliorating oxidative stress and neuroinflammation in d‑galactose-treated mice. Zhang Z; Yang H; Yang J; Xie J; Xu J; Liu C; Wu C Int Immunopharmacol; 2019 Feb; 67():78-86. PubMed ID: 30537634 [TBL] [Abstract][Full Text] [Related]
2. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice. Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318 [TBL] [Abstract][Full Text] [Related]
3. Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB, MAPKs and Akt signaling pathways. Wang X; Wang C; Wang J; Zhao S; Zhang K; Wang J; Zhang W; Wu C; Yang J Neuropharmacology; 2014 Apr; 79():642-56. PubMed ID: 24467851 [TBL] [Abstract][Full Text] [Related]
4. Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease. Wang CM; Liu MY; Wang F; Wei MJ; Wang S; Wu CF; Yang JY Pharmacol Biochem Behav; 2013 May; 106():57-67. PubMed ID: 23541491 [TBL] [Abstract][Full Text] [Related]
5. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model. Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592 [TBL] [Abstract][Full Text] [Related]
6. Pseudoginsenoside-F11 promotes functional recovery after transient cerebral ischemia by regulating the microglia/macrophage polarization in rats. Hou Y; Yang D; Wang X; Wang H; Zhang H; Wang P; Liu Y; Gao X; Yang J; Wu C Int Immunopharmacol; 2021 Oct; 99():107896. PubMed ID: 34246061 [TBL] [Abstract][Full Text] [Related]
7. Pseudoginsenoside-F11 alleviates oligomeric β-amyloid-induced endosome-lysosome defects in microglia. Yao XC; Xue X; Zhang HT; Zhu MM; Yang XW; Wu CF; Yang JY Traffic; 2019 Jan; 20(1):61-70. PubMed ID: 30375163 [TBL] [Abstract][Full Text] [Related]
8. Pseudoginsenoside-F11 Protects against Transient Cerebral Ischemia Injury in Rats Involving Repressing Calcium Overload. Zhang T; Wu C; Yang X; Liu Y; Yang H; Yuan L; Liu Y; Sun S; Yang J Neuroscience; 2019 Jul; 411():86-104. PubMed ID: 31129202 [TBL] [Abstract][Full Text] [Related]
9. Pseudoginsenoside-F11 Accelerates Microglial Phagocytosis of Myelin Debris and Attenuates Cerebral Ischemic Injury Through Complement Receptor 3. Liu Y; Wu C; Hou Z; Fu X; Yuan L; Sun S; Zhang H; Yang D; Yao X; Yang J Neuroscience; 2020 Feb; 426():33-49. PubMed ID: 31790669 [TBL] [Abstract][Full Text] [Related]
10. Pseudoginsenoside-F11 improves long-term neurological function and promotes neurogenesis after transient cerebral ischemia in mice. Yuan L; Sun S; Pan X; Zheng L; Li Y; Yang J; Wu C Neurochem Int; 2020 Feb; 133():104586. PubMed ID: 31756514 [TBL] [Abstract][Full Text] [Related]
11. Vitamin C alleviates LPS-induced cognitive impairment in mice by suppressing neuroinflammation and oxidative stress. Zhang XY; Xu ZP; Wang W; Cao JB; Fu Q; Zhao WX; Li Y; Huo XL; Zhang LM; Li YF; Mi WD Int Immunopharmacol; 2018 Dec; 65():438-447. PubMed ID: 30388518 [TBL] [Abstract][Full Text] [Related]
12. Supplementation of lycopene attenuates oxidative stress induced neuroinflammation and cognitive impairment via Nrf2/NF-κB transcriptional pathway. Zhao B; Ren B; Guo R; Zhang W; Ma S; Yao Y; Yuan T; Liu Z; Liu X Food Chem Toxicol; 2017 Nov; 109(Pt 1):505-516. PubMed ID: 28974442 [TBL] [Abstract][Full Text] [Related]
13. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens. Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348 [TBL] [Abstract][Full Text] [Related]
14. Aqueous extracts of se-enriched Auricularia auricular attenuates D-galactose-induced cognitive deficits, oxidative stress and neuroinflammation via suppressing RAGE/MAPK/NF-κB pathway. Wang J; Zhang T; Liu X; Fan H; Wei C Neurosci Lett; 2019 Jun; 704():106-111. PubMed ID: 30953738 [TBL] [Abstract][Full Text] [Related]
15. Pseudoginsenoside F11 ameliorates the dysfunction of the autophagy-lysosomal pathway by activating calcineurin-mediated TFEB nuclear translocation in neuron during permanent cerebral ischemia. Fu X; Liu Y; Zhang H; Yu X; Wang X; Wu C; Yang J Exp Neurol; 2021 Apr; 338():113598. PubMed ID: 33422553 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of sesamol on systemic oxidative stress-induced cognitive impairments via regulation of Nrf2/Keap1 pathway. Ren B; Yuan T; Diao Z; Zhang C; Liu Z; Liu X Food Funct; 2018 Nov; 9(11):5912-5924. PubMed ID: 30375618 [TBL] [Abstract][Full Text] [Related]
17. Pseudoginsenoside-F11 reduces cognitive impairment and white matter injury in vascular dementia by alleviating autophagy-lysosomal pathway deficiency. Wang H; Liu Y; Cui M; Guo Z; Zhao Y; Yang J; Wu C Phytomedicine; 2024 Oct; 133():155883. PubMed ID: 39059268 [TBL] [Abstract][Full Text] [Related]
18. A new ocotillol-type ginsenoside from stems and leaves of Qi Z; Wang Z; Zhou B; Fu S; Hong T; Li P; Liu J Nat Prod Res; 2020 Sep; 34(17):2474-2481. PubMed ID: 30602312 [TBL] [Abstract][Full Text] [Related]
19. Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects. Liu YY; Zhang TY; Xue X; Liu DM; Zhang HT; Yuan LL; Liu YL; Yang HL; Sun SB; Zhang C; Xu HS; Wu CF; Yang JY CNS Neurosci Ther; 2017 Jul; 23(7):567-579. PubMed ID: 28485547 [TBL] [Abstract][Full Text] [Related]
20. Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects. Mirahmadi SM; Shahmohammadi A; Rousta AM; Azadi MR; Fahanik-Babaei J; Baluchnejadmojarad T; Roghani M Cytokine; 2018 Apr; 104():151-159. PubMed ID: 29102164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]